Lidothol Gel
Product Images NDC 87063-218

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 87063-218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Insert (1) (Lidothol Package Insert 102424 01 (1))

Package Insert (1) (Lidothol Package Insert 102424 01 (1))
The text provides detailed Dosage and Administration guidelines for Lidothol™, a topical gel containing Lidocaine HCL and Menthol. The text covers application instructions, handling, disposal, side effects, overdosage considerations, and systemic reactions information. It also includes a list of drugs associated with methemoglobinemia. The product description, including ingredients and pharmacology details, and manufacturer contact information are also included. Users are recommended to follow the instructions closely, take note of possible adverse reactions, and dispose of the product properly.*
FDA Label Image

Package Insert (2) (Lidothol Package Insert 102424 02 (1))

Package Insert (2) (Lidothol Package Insert 102424 02 (1))
Lidothol™ is a medication indicated for pain relief related to arthritis, backache, cramps, strains, and soreness, among others. It is administered topically on intact skin. The drug's distribution, metabolism, and excretion are detailed, as well as contraindications, warnings (including the risk of methemoglobinemia), precautions, and potential drug interactions. It is essential to monitor patients closely, especially those with specific conditions, to prevent adverse effects due to excessive dosing or other possible complications. Additionally, certain patient groups, such as pregnant or nursing mothers and pediatric patients, require special consideration when using Lidothol™.*
FDA Label Image

1 (Label)

1 (Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.